Quick Answer
EUDA Health Holdings Ltd reported R&D Expense of $17.2 thousand for fiscal year 2022.
EUDA Health Holdings Ltd R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2022 | $17.2K | -86.7% |
| 2021 | $129.3K | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| March 31, 2022 | $2.9K | — | — |
- EUDA Health Holdings Ltd showed a decrease of -86.7% in R&D Expense compared to the prior fiscal year.
- Over the 2021–2022 period, EUDA Health Holdings Ltd’s r&d expense has declined by 86.7% (from $129.3 thousand to $17.2 thousand).
- The most recent figure is from EUDA Health Holdings Ltd’s fiscal year 2022 report (Form 10-K), filed with the SEC on June 28, 2023.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: